Medicija has acquired Saulės Šeimos Medicinos Centras
Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.
Medicija is a leading fertility services provider in Lithuania with a growing offering across multiple specialist consultation areas. It operates three modern clinics in Vilnius, Kaunas and Klaipėda.
Founded 25 years ago by five family doctors, Saulės Šeimos Medicinos Centras is the largest primary healthcare provider in the Kaunas region, operating four state-of-the-art clinics in the city. The company serves approximately 28,000 registered patients and employs 170 people.
Oaklins’ team in Lithuania acted as the financial advisor to Medicija in the acquisition. This transaction marks the team’s third engagement with Medicija, strengthening the company’s position in the Lithuanian healthcare services market and laying a solid foundation for future growth.
Sprechen Sie mit dem Deal-Team
Relevante Transaktionen
UKAT Group has acquired Bayberry Limited
UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.
Weitere InformationenQuimpharma has completed the divestiture of a product portfolio to Megalabs
Quimpharma has completed the divestiture of a product portfolio to Megalabs México.
Weitere InformationenIXICO has completed a fundraising
IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.
Weitere Informationen